Kira Misura

Kira brings to Salish more than 15 years of industry experience in genomics, protein therapeutics and technology platforms. She was most recently at Lundbeck as Vice President of Scientific Computing, and before that, at Alder Biopharmaceuticals as Vice President in R&D. She worked with both companies to develop technology and manufacturing capabilities for pipeline projects as well as Alder’s first approved therapy.

Kira has also held scientific, technical and leadership positions at both Amgen and Merck. She gained extensive experience in biomarker discovery and development as well as discovery and development of protein therapeutics across oncology, immunology and neurobiology.

Kira completed a postdoctoral fellowship at the University of Washington and received a Ph.D. in Biophysics from Stanford University. She holds a BA degree in Chemistry and Biochemistry from Brandeis University.